Bioprinting 3D tissues for testing COVID-19 therapeutics: an interview with CLECELL
In this editorial/interview, Hyo-Kyung, Bae (CLECELL, Gyeonggi-do, Republic of Korea) describes how the team at CLECELL are utilizing bioprinting techniques to develop tissue models for testing vaccines and therapeutics for COVID-19. As teams of scientists around the world work to develop strategies for the treatments and prevention of COVID-19 through therapeutics and vaccination, there is a unique opportunity for 3D bioprinted tissue models to aid the early R&D phases. In this editorial and interview, Hyo-Kyung, Bae (CLECELL, Gyeonggi-do, Republic of Korea) describes how her team are utilizing bioprinting techniques to develop tissue models and how these can be adapted for...